Literature DB >> 1752467

Postprandial hypergastrinaemia in patients with colorectal cancer.

K Wong1, K Beardshall, C M Waters, J Calam, G J Poston.   

Abstract

Gastrin is trophic to colon cancers that possess gastrin receptors. Whether fasting serum gastrin concentrations are high in patients with colon cancer is controversial. We therefore studied the effect of food on serum gastrin concentrations in patients with colon cancer and control subjects. Fasting serum gastrin was greater, though not significantly so, in patients with colon cancer before surgery (mean (SD) 17.4 (3.6) pmol/l, n = 16) compared with control subjects (12.6 (1.9) pmol/l, n = 14). Postprandial increases in serum gastrin were significantly and persistently higher than normal in the cancer patients. These increases were due to a subset of six patients with serum gastrin concentrations greater than the control mean + 2 SD at 20 and 40 minutes (62 pmol/l-146 pmol/l). Four of the six patients had intra-abdominal metastases. The extent of the increase may well correlate with that of the disease. Surgical resection of the tumour resulted in a fall in serum gastrin values and probably reflects the cause of the hypergastrinaemia. Hypergastrinaemia may, therefore, be an important aetiological factor in colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752467      PMCID: PMC1379166          DOI: 10.1136/gut.32.11.1352

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Elevated gastrin levels in patients with colon cancer or adenomatous polyps.

Authors:  J P Smith; J G Wood; T E Solomon
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

Review 2.  Growth factors and intestinal neoplasms.

Authors:  C M Townsend; R D Beauchamp; P Singh; J C Thompson
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

3.  Serum levels of gastrin in patients with colorectal neoplasia.

Authors:  H Suzuki; K Matsumoto; H Terashima
Journal:  Dis Colon Rectum       Date:  1988-09       Impact factor: 4.585

4.  Stimulation of growth of a colon cancer cell line by gastrin.

Authors:  C J Kusyk; N O McNiel; L R Johnson
Journal:  Am J Physiol       Date:  1986-11

5.  Gastrin receptors in normal and malignant gastrointestinal mucosa: age-associated changes.

Authors:  P Singh; B Rae-Venter; C M Townsend; T Khalil; J C Thompson
Journal:  Am J Physiol       Date:  1985-12

6.  Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice.

Authors:  P Singh; J P Walker; C M Townsend; J C Thompson
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

7.  Trophic effects of gastrin on colorectal neoplasms in the rat.

Authors:  D B McGregor; R D Jones; D A Karlin; M M Romsdahl
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

8.  Gastrin stimulates growth of colon cancer.

Authors:  O E Winsett; C M Townsend; E J Glass; J C Thompson
Journal:  Surgery       Date:  1986-03       Impact factor: 3.982

9.  Hormonal control of human colon carcinoma cell growth in serum-free medium.

Authors:  H Murakami; H Masui
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells.

Authors:  K R Sirinek; B A Levine; M P Moyer
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

View more
  18 in total

1.  Helicobacter pylori infection and colorectal carcinoma: is there a causal association?

Authors:  Sergei F Tatishchev; Christine Vanbeek; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-12

2.  Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer.

Authors:  Grzegorz Bombski; Anita Gasiorowska; Daria Orszulak-Michalak; Beata Neneman; Justyna Kotynia; Janusz Strzelczyk; Adam Janiak; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2002

3.  Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia.

Authors:  M Renga; G Brandi; G M Paganelli; C Calabrese; S Papa; A Tosti; P Tomassetti; M Miglioli; G Biasco
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

Review 4.  Acid suppression and claims of genotoxicity. What have we learned?

Authors:  R A Goodlad
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 5.  Cell proliferation in gastrointestinal mucosa.

Authors:  W M Wong; N A Wright
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

6.  Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma.

Authors:  R K Siddheshwar; J C Gray; S B Kelly
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

7.  Atrophic gastritis and the risk of incident colorectal cancer.

Authors:  Adeyinka O Laiyemo; Farin Kamangar; Pamela M Marcus; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2009-10-17       Impact factor: 2.506

8.  Prognostic significance of gastrin expression in patients undergoing R0 gastrectomy for adenocarcinoma.

Authors:  Michael R Stephens; Andrew N Hopper; Wyn G Lewis; Guy Blackshaw; Paul Edwards; Becky Osborne; Ian W Thompson
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

9.  Identification of progastrin derived peptides in colorectal carcinoma extracts.

Authors:  J Nemeth; B Taylor; S Pauwels; A Varro; G J Dockray
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 10.  Gastrin, gastrin receptors and colorectal carcinoma.

Authors:  G S Baldwin; A Shulkes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.